Understanding Regional Variation in Medicare Expenditures for Initial Episodes of Prostate Cancer Care

OBJECTIVES: To evaluate the contributions of patient and treatment factors to overall expenditures and regional variation for initial treatment of localized prostate cancer (CaP) in the Medicare program. RESEARCH DESIGN: Using the Surveillance, Epidemiology, and End Results-Medicare database, we identified 47,517 beneficiaries with localized CaP during 2005-2009 and matched noncancer controls. We employed hierarchical generalized linear models to estimate risk-standardized cancer-related expenditures for each hospital referral region. To identify key contributors to the variation, we sequentially added patient characteristics, treatment intensity (the percentage of patients receiving curative treatments), ancillary procedures (biopsy, hormone therapy, and imaging), and specific treatment modalities into the model. We categorized the expenditures according to the type of services to identify their relative impact on the expenditure variations. RESULTS: The mean expenditure on CaP-related care per CaP beneficiary was $15,900, including $1800 on surgery, $11,200 on radiotherapy, and $1900 on ancillary procedures. The expenditure difference between quintiles 5 and 1 was $6200. Patient characteristics explained 8.4% of this difference. Treatment intensity and treatment modalities accounted for an additional 21.2% and 31.2% of the variation, respectively. Between the highest and lowest expenditure quintiles, the difference in radiotherapy expenditure was $5000, whereas that in surgery or ancillary procedures was <$200. CONCLUSIONS: There is substantial geographic variation in CaP expenditures, and the specific modality of radiotherapy is the most important contributor to this variation. Efforts to address the CaP care costs, such as bundled payment development, require targeting both treatment intensity and use of costly modalities

Business · Cancer · Prostate cancer · Regional variation · Sociology · Variation (astronomy) · Demography · Economic and Financial Impacts of Cancer · Health Systems, Economic Evaluations, Quality of Life · Internal Medicine · Medicine · Prostate Cancer Diagnosis and Treatment

• Associations Among Health Literacy, End‐of‐Life Care Expenditures, and Rurality

  Open Access•Kewei Sylvia Shi, Peiyin Hung et al.•The Journal of Rural Health•2021

  Añadir item

• Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (Upin) Crosswalk for Medicare Data

  Helen M Parsons, Helen Parsons et al.•Medical Care•2017

  Añadir item

• An Evaluation of Radical Prostatectomy at Veterans Affairs Medical Centers

  Timothy J Wilt, Diane C Cowper et al.•Medical Care•1999

  Añadir item

• Comorbidity Measures for Use with Administrative Data

  Anne Elixhauser, Claudia Steiner et al.•Medical Care•1998

  Añadir item

• A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data

  Carl van Walraven, Peter C Austin et al.•Medical Care•2009

  Añadir item

• Overview of Methods to Estimate the Medical Costs of Cancer

  William E Barlow•Medical Care•2009

  Añadir item